en

PRODUCT DETAIL

Sitagavia 25 mg filmom obalené tablety

Code 3816D
MA number 18/0055/20-S
Product Form: tbl flm 30x25 mg (blis.OPA/Al/PVC/Al)
MA Status: R - Valid Marketing Authorisation
Type of procedure: Decentralised
Therapeutic Class: 18 - ANTIDIABETICA (VRÁTANE INZULÍNU)
ATC:
A ALIMENTARY TRACT AND METABOLISM
A10 DRUGS USED IN DIABETES
A10B Blood glucose lowering drugs, excl. insulins
A10BH Dipeptidyl peptidase 4 (DPP-4) inhibitors
A10BH01 Sitagliptin
Shelf life: 24
Container: blister OPA/Al/PVC/Al
Route of admin.: Oral use
Prescription Status: Medicinal product subject to medical prescription.
Legal basis: Article 10(1) generic application
MA issued: 16.03.2020
Validity: 16.03.2025
MA renewed: Renewal application submitted
Dokument: VHS_súhrn_Sitagavia 18_0055-57_20-S.pdf  
Dokument: VHS_Sitagavia 18_0055-57_20-S.pdf  
PIL: PIL_Sitagavia_04.2022.pdf  
SPC: SPC_Sitagavia_01.2023.pdf  
Safety feature Yes
Data update: 24.01.2023
eu-flag.png sk-flag.png